Vaxil Bio Ltd.

TSXV:VXL Canada Healthcare — Biotechnology

Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company is headquartered in Toronto, Canada.

Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the full company research view.
Results 2026-05-28
Open PDF
Interim MD&A - English.pdf
Results 2026-05-28
Open PDF
Interim financial statements/report – English.pdf
Results 2026-05-01
Open PDF
Annual MD&A - English.pdf
Results 2026-05-01
Open PDF
Audited annual financial statements – English.pdf
News 2025-12-16
Report of exempt distribution (45-106F1).pdf
Transactions 2025-12-04 Financing
Open PDF
Vaxil Announces Close of Previously Announced Non-Brokered Private Placement and Update on Board of Directors
News release - English.pdf
Results 2025-11-27 Financials
Open PDF
Interim financial statements/report – English.pdf
Results 2025-11-27 Financials
Open PDF
Interim MD&A - English.pdf
Transactions 2025-11-24 Financing
Open PDF
Vaxil Announces Update on Non-Brokered Private Placement
News release - English.pdf
News 2025-10-29
Open PDF
News release - English.pdf
Results 2025-08-29 Financials
Open PDF
Interim MD&A - English.pdf
Results 2025-08-29 Financials
Open PDF
Interim financial statements/report – English.pdf

Showing 12 of 22 items in this period.